Journey Medical Corporation: shareholders and insiders

DERMNASDAQHealthcare · Pharmaceutical Preparations

Price

$3.69

November 18, 2026Market cap $90M

What Ploutos Investor adds for Journey Medical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 18, 2025 to Jul 2, 2026, from their own Form 4 filings.

8 Form 4s

Bought on the market

–

nobody

Sold on the market

–

nobody

From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

No trades under these filters.

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by DERM's officers and directors from 2022 up to November 17, 2025, 4 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%Oct 9, 2026 Latest filing
  • Wasatch Advisors LP
    Share of class11.0%
  • Tang Capital Managementwith 5 more persons
    Share of class8.00%
Fell to 5% or less (1)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Vanguard Capital Management3.59%Jul 31, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter-37%
  • Millennium Mgmt (Englander)
    In the quarter+118%
  • D.E. Shaw
    In the quarter
  • Renaissance Technologies
    In the quarter-0.3%
  • AQR Capital
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 12.2% of its shares outstanding were held short, -2.2% since the report before.

Shares held short
2.99M
12.2%
Since the report before3.06M on Sep 30, 2026
-2.2%
16.6
180.2K
More days to cover thanof 4,578 US-listed companies with enough volume
99%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 81.4K
  • Nov 15, 2023: Shares held short 44.6K
  • Nov 30, 2023: Shares held short 220.1K
  • Dec 15, 2023: Shares held short 174.2K
  • Dec 29, 2023: Shares held short 54.6K
  • Jan 12, 2024: Shares held short 48.7K
  • Jan 31, 2024: Shares held short 70.7K
  • Feb 15, 2024: Shares held short 60.3K
  • Feb 29, 2024: Shares held short 64.4K
  • Mar 15, 2024: Shares held short 79.2K
  • Mar 28, 2024: Shares held short 148.1K
  • Apr 15, 2024: Shares held short 235.5K
  • Apr 30, 2024: Shares held short 283.3K
  • May 15, 2024: Shares held short 280.1K
  • May 31, 2024: Shares held short 287.8K
  • Jun 14, 2024: Shares held short 286.0K
  • Jun 28, 2024: Shares held short 353.2K
  • Jul 15, 2024: Shares held short 325.6K
  • Jul 31, 2024: Shares held short 161.0K
  • Aug 15, 2024: Shares held short 127.5K
  • Aug 30, 2024: Shares held short 92.0K
  • Sep 13, 2024: Shares held short 79.4K
  • Sep 30, 2024: Shares held short 87.7K
  • Oct 15, 2024: Shares held short 76.7K
  • Oct 31, 2024: Shares held short 60.7K
  • Nov 15, 2024: Shares held short 66.2K
  • Nov 29, 2024: Shares held short 76.7K
  • Dec 13, 2024: Shares held short 66.9K
  • Dec 31, 2024: Shares held short 76.8K
  • Jan 15, 2025: Shares held short 78.7K
  • Jan 31, 2025: Shares held short 83.8K
  • Feb 14, 2025: Shares held short 94.1K
  • Feb 28, 2025: Shares held short 113.4K
  • Mar 14, 2025: Shares held short 117.3K
  • Mar 31, 2025: Shares held short 150.1K
  • Apr 15, 2025: Shares held short 252.1K
  • Apr 30, 2025: Shares held short 332.4K
  • May 15, 2025: Shares held short 316.0K
  • May 30, 2025: Shares held short 393.7K
  • Jun 13, 2025: Shares held short 549.6K
  • Jun 30, 2025: Shares held short 984.2K
  • Jul 15, 2025: Shares held short 1.11M
  • Jul 31, 2025: Shares held short 1.21M
  • Aug 15, 2025: Shares held short 1.45M
  • Aug 29, 2025: Shares held short 1.40M
  • Sep 15, 2025: Shares held short 1.51M
  • Sep 30, 2025: Shares held short 1.58M
  • Oct 15, 2025: Shares held short 1.77M
  • Oct 31, 2025: Shares held short 2.07M
  • Nov 14, 2025: Shares held short 2.36M
  • Nov 28, 2025: Shares held short 2.39M
  • Dec 15, 2025: Shares held short 2.43M
  • Dec 31, 2025: Shares held short 2.44M
  • Jan 15, 2026: Shares held short 2.48M
  • Jan 30, 2026: Shares held short 2.56M
  • Feb 13, 2026: Shares held short 2.57M
  • Feb 27, 2026: Shares held short 2.54M
  • Mar 13, 2026: Shares held short 2.63M
  • Mar 31, 2026: Shares held short 3.46M
  • Apr 15, 2026: Shares held short 3.72M
  • Apr 30, 2026: Shares held short 3.67M
  • May 15, 2026: Shares held short 3.47M
  • May 29, 2026: Shares held short 3.51M
  • Jun 15, 2026: Shares held short 3.52M
  • Jun 30, 2026: Shares held short 2.99M
  • Jul 15, 2026: Shares held short 3.05M
  • Jul 31, 2026: Shares held short 2.87M
  • Aug 14, 2026: Shares held short 2.92M
  • Aug 31, 2026: Shares held short 2.96M
  • Sep 15, 2026: Shares held short 2.93M
  • Sep 30, 2026: Shares held short 3.06M
  • Oct 15, 2026: Shares held short 2.99M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading44.1% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 44.1% of the shares in the reported trades were short sales, against 35.6% in the 14 before.

Last 14 sessionsOct 29, 2026 – Nov 17, 2026
44.1%
The 14 beforeOct 9, 2026 – Oct 28, 2026
35.6%
Change
+8.5 pts
Short sales a dayon average, of 96.6K shares
42.6K
More than atof 3,659 US-listed companies, same days
31%
Median of alleight in ten from 34.6% to 63.7%
50.3%
  • Oct 9, 2026: Short sales 40.5%
  • Oct 12, 2026: Short sales 10.8%
  • Oct 13, 2026: Short sales 20.6%
  • Oct 14, 2026: Short sales 37.6%
  • Oct 15, 2026: Short sales 32.3%
  • Oct 16, 2026: Short sales 54.6%
  • Oct 19, 2026: Short sales 18.9%
  • Oct 20, 2026: Short sales 42.5%
  • Oct 21, 2026: Short sales 45.1%
  • Oct 22, 2026: Short sales 51.8%
  • Oct 23, 2026: Short sales 63.3%
  • Oct 26, 2026: Short sales 39.7%
  • Oct 27, 2026: Short sales 28.9%
  • Oct 28, 2026: Short sales 49.7%
  • Oct 29, 2026: Short sales 46.9%
  • Oct 30, 2026: Short sales 38.6%
  • Nov 2, 2026: Short sales 48.5%
  • Nov 3, 2026: Short sales 33.5%
  • Nov 4, 2026: Short sales 47.7%
  • Nov 5, 2026: Short sales 60.7%
  • Nov 6, 2026: Short sales 68.5%
  • Nov 9, 2026: Short sales 58.3%
  • Nov 10, 2026: Short sales 38.8%
  • Nov 11, 2026: Short sales 46.2%
  • Nov 12, 2026: Short sales 61.4%
  • Nov 13, 2026: Short sales 42.5%
  • Nov 16, 2026: Short sales 32.6%
  • Nov 17, 2026: Short sales 39.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

4.16M Insiders' shares
  • Claude MaraouiPresident & CEO
    Directly2.35M
  • Ramsey AlloushCOO
    Directly504.8K
  • Lindsay A Md RosenwaldDirector
    Directly397.6K
  • Justin Adam SmithDirector
    Directly231.6K
  • Joseph BeneschCFO
    Directly203.6K
  • Miranda Jayne ToledanoDirector
    Directly168.6K
  • Neil HerskowitzDirector
    Directly168.6K
  • Jeffrey PaleyDirector
    Directly70.7K
  • Michael Cooper PearceDirector
    Directly67.2K

A lower bound: it counts only the 9 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

3 ETFs holding it0.02% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.02%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

3 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

71 Managers, Q2 2026$75M Value of their positions
  • Q3 2025: Managers 68
  • Q4 2025: Managers 77
  • Q1 2026: Managers 72
  • Q2 2026: Managers 71

Institutional investors by quarter

The fund managers holding DERM, quarter by quarter, from Q4 2014 to Q2 2025, 36 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 71 managers held 10.66M shares, worth $75M. During the quarter 23 opened a position, 23 closed one, 19 added and 22 trimmed.

The largest holders, Q2 2026

  • Wasatch Advisors
    In the quarter+34%
  • Tang Capital Management
    In the quarter
  • Vanguard Capital Management
    In the quarter-38%
  • Punch & Associates Investment Management
    In the quarter
  • Pale Fire Capital SE
    In the quarter+9.7%
  • Opaleye Management
    In the quarter-64%
  • Summit Financial
    In the quarter-8.7%
  • Jane Street Group
    In the quarter
  • Diametric Capital
    In the quarter+51%
  • Ikarian Capital
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Journey Medical's filings show?

Who buys and sells is one part of Journey Medical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about DERM's shareholders

Didn't find what you were looking for?

Ask us
Have DERM's insiders bought or sold?

From Jun 26, 2026 to Jul 2, 2026 Journey Medical's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold DERM?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $1.6M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.